SHC
Sotera Health Company Common Stock
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Best Diagnostics Stocks 2026 →
Sotera Health (SHC) Stock: Buy, Sell, or Hold?
$16.44
+0.17 (+1.04%)
▲
5d:
+0.31%
30d:
-9.72%
90d:
-13.56%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (91%)
Quality Score
56/100
Position
OVERSOLD
30-Day Fair Range
$16.76 – $18.51
Position: OVERSOLD
Forward P/E & Valuation
15.4x
FAIR
vs 16.5x historical avg
Wall Street Target
$21.44
+30.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$15.65 / $18.96
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: SHC shows positive signals but monitor for confirmation. Market pricing in 2.2% decline. Moderate conviction.
Get Alerted When SHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$23.73
Based on 6.2% avg growth
INTRINSIC VALUE TODAY
$14.73
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SHC is currently trading at $16.44, which is considered oversold relative to its 30-day fair value range of $16.76 to $18.51. The stock's valuation (Forward PE: 15.4) is in line with its historical norms (16.5). Remarkably, the market is currently pricing in an annual earnings decline of 2.2% over the next few years. This pessimistic expectation contrasts with the company's recent 17.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SHC is in a strong uptrend. Immediate support is located at $15.64, while resistance sits at $18.96.
Market Sentiment: SHC scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $21.44 (+30.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SHC is in a strong uptrend. Immediate support is located at $15.64, while resistance sits at $18.96.
Market Sentiment: SHC scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $21.44 (+30.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$16.76 -
$18.51
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.5%
Trading Range & Key Levels
30-Day Trading Range
$16.76 -
$18.51
Current vs Trading Range
OVERSOLD
Support Level
$15.65
Resistance Level
$18.96
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 30.4% below Wall St target ($21.44)
- BULLISH: Bottoming setup score 60/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
15.44
Wall Street Target
$21.44
(+30.4%)
Revenue Growth (YoY)
4.4%
Earnings Growth (YoY)
17.6%
Profit Margin
14.1%
Valuation Discount vs History
-2.2% cheaper
PE vs Historical
15.4 vs 16.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.2%
(market-implied from PE analysis)
1-Year Target
$16.08
(-2%)
2-Year Target
$15.72
(-4%)
3-Year Target
$15.38
(-7%)
3-Yr Target (if PE normalizes)
(PE: 15→17)
$16.44
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 8.4%)
$26.91
(+64%)
Base:
(SPY PE: 15.4, Growth: 8.4%)
$20.91
(+27%)
Bear:
(PE: 13.1, Growth: 8.4%)
$17.78
(+8%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 27.12 | Current EPS (TTM): $0.60
Bull Case
$31.77
(+93%)
Analyst growth 77.5%, PE expands to 29.8
Base Case
$28.88
(+76%)
Market implied 77.5%, PE stable at 27.1
Bear Case
$11.06
(-33%)
Severe decline -20.0%, PE contracts to 23.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.4 to 16.5
Stabilization Target:
$17.57
(+6.9%)
PE Expansion Potential:
+6.9%
Share SHC Analysis
Share this live SHC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SHC)
Bullish
5 Retail Mentions
Reddit / WSB Comments
4
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
May 26, 2026
Daily AI digest
AI Retail Discussion Summary:
The latest Yahoo Finance news article identifies Sotera Health (SHC) as one of the 145 undervalued US stocks based on cash flows, with an estimated discount to fair value of 20.6%. The article also discusses Sotera Health's strong financial performance and growth prospects, as well as concerns regarding interest payments.
Key Retail Themes:
undervalued stock
financial performance
growth prospects
interest payments
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:45 AM ET
Data refreshes hourly during market hours. Next update: 3:45 AM
Data refreshes hourly during market hours. Next update: 3:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SHC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$201 | 51 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$416 | 65 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$752 | 47 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$260 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SHC Research Pages
